Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway

Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway

(2010) Chang-Liang Peng et al.   CANCER BIOLOGY & THERAPY

CTGF enhances migration and MMP-13 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells

(2009) Tzu-Wei Tan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Glial cell-derived neurotrophic factor increases migration of human chondrosarcoma cells via ERK and NF-κB pathways

(2009) Chen-Ming Su et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway

(2009) Kwong-Kwok Wong   Recent Patents on Anti-Cancer Drug Discovery

The p38 MAPK stress pathway as a tumor suppressor or more?

(2008) Mathew Loesch   Frontiers in Bioscience-Landmark

Hyaluronan inhibits IL-1β-stimulated collagenase production via down-regulation of phosphorylated p38 in SW-1353 human chondrosarcoma cells

(2008) Sohel M. Julovi et al.   Modern Rheumatology

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo

(2008) A Bessard et al.   ONCOGENE

Bcl-2 family proteins and cancer

(2008) K W Yip et al.   ONCOGENE

The Clinical Approach Towards Chondrosarcoma

(2008) H. Gelderblom et al.   ONCOLOGIST

Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer

(2008) T. Boutros et al.   PHARMACOLOGICAL REVIEWS